Pesquisar
Ascendis Pharma A/S
ASNDAdicionar à lista de desejos
261.580USD
+23.570+9.90%
Fechamento 06/25, 16:00（ET）Cotações atrasadas em 15 min
16.21BValor de mercado
37.69P/L TTM
Mais detalhes de Ascendis Pharma A/S Empresa
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Informações de Ascendis Pharma A/S
Código da empresaASND
Nome da EmpresaAscendis Pharma A/S
Data de listagemJan 28, 2015
CEOMoller Mikkelsen (Jan)
Número de funcionários- -
Tipo de títulosDepository Receipt
Fim do ano fiscalJan 28
EndereçoTuborg Boulevard 12
CidadeHELLERUP
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísDenmark
Código postal2900
Telefone4570222244
Sitehttps://ascendispharma.dk/
Código da empresaASND
Data de listagemJan 28, 2015
CEOMoller Mikkelsen (Jan)
Executivos da empresa Ascendis Pharma A/S
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+66.49%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.66K
+40.20%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
--
-100.00%
Dr. Stina Singel, M.D., Ph.D.
Dr. Stina Singel, M.D., Ph.D.
Executive Vice President, Head of Clinical Development, Oncology
Executive Vice President, Head of Clinical Development, Oncology
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
--
-100.00%
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+66.49%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.66K
+40.20%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
--
-100.00%
Perguntas frequentes
Quem são os cinco principais acionistas de Ascendis Pharma A/S?
Os cinco principais acionistas de Ascendis Pharma A/S são: Mr. Flemming Steen Jensen
Quantas instituições possuem ações da Ascendis Pharma A/S (ASND)?
Em 2026Q1, 582 instituições possuíam ações da Ascendis Pharma A/S, com valor de mercado aproximado de 69.20M, representando 111.42% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1676383.00.
Qual é a maior fonte de receita da Ascendis Pharma A/S?
Em 2026Q1, o segmento de negócios Commercial sale of products gerou a maior receita para Ascendis Pharma A/S, totalizando 683.57M e representando 94.92% da receita total.
